Medically reviewed by Dr. Ajit Kumar, MD (Medicine) | Member, Editorial Board, Medimadad Health Editorial Team Millions of people are taking Ozempic, Wegovy, and Mounjaro with impressive results. But a growing body of research is asking a question that very few people in the weight loss conversation are talking about: why do so many patients […]
26 Articles
Evidence-based coverage of weight loss drugs, GLP-1 science, metabolic health, and fat loss strategies. Includes the latest research on Ozempic, Mounjaro, Wegovy, tirzepatide, and semaglutide — reviewed by Dr. Ajit Kumar, MD (Medicine) | MA Psychology.
⚕️ Medically Reviewed This article has been reviewed by Dr. Ajit Kumar, MD (Medicine), Healthcare Consultant. Content is for informational purposes only and does not constitute medical advice. Always consult your doctor before making health decisions. As GLP-1 drugs have dominated health headlines, a provocative question has emerged: if a weekly injection can produce 15–20% […]
⚕️ Medically Reviewed This article has been reviewed by Dr. Ajit Kumar, MD (Medicine), Healthcare Consultant. Content is for informational purposes only and does not constitute medical advice. Always consult your doctor before making health decisions. When tirzepatide (Mounjaro/Zepbound) was approved, it was described as a dual GLP-1/GIP receptor agonist. Most of the attention went […]
⚕️ Medically Reviewed This article has been reviewed by Dr. Ajit Kumar, MD (Medicine), Healthcare Consultant. Content is for informational purposes only and does not constitute medical advice. Always consult your doctor before making health decisions. Sleep apnea affects an estimated 100 million people worldwide, and India carries a disproportionate burden — with obesity, anatomical […]
⚕️ Medically Reviewed This article has been reviewed by Dr. Ajit Kumar, MD (Medicine), Healthcare Consultant. Content is for informational purposes only and does not constitute medical advice. Always consult your doctor before making health decisions. In August 2023, the New England Journal of Medicine published results that changed cardiovascular medicine. The SELECT trial — […]
⚕️ Medically Reviewed This article has been reviewed by Dr. Ajit Kumar, MD (Medicine), Healthcare Consultant. Content is for informational purposes only and does not constitute medical advice. Always consult your doctor before making health decisions. For the first time in obesity medicine, doctors have two genuinely different classes of injectable weight loss drugs to […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD Medicine — Healthcare Consultant and Health Educator, Founder of Medimadad. About the Author | Editorial Policy Millions of people have started semaglutide injections and experienced dramatic weight loss. But what happens when they stop? The answer, backed by rigorous clinical data, is uncomfortable — and it has […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD Medicine — Healthcare Consultant and Health Educator, Founder of Medimadad. About the Author | Editorial Policy Most patients with kidney disease are told to be cautious with new medications. Yet one of the largest kidney trials ever conducted has just delivered a striking verdict on semaglutide — […]
🦺Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Everyone knows Ozempic and Wegovy for one reason: weight loss. But in 2026, a wave of new research is revealing something that is catching even doctors off guard. These GLP-1 receptor agonist drugs […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Weight loss surgery dominated obesity treatment for over two decades. Surgeons could not keep up with demand. Hospital waiting lists stretched months long. Then, almost overnight, the operating rooms started getting quieter. The reason […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy For millions of people managing type 2 diabetes or considering GLP-1 therapy for weight loss, injections have always been the biggest barrier. That barrier may now be coming down. Novo Nordisk has launched an […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Two of the most prescribed weight loss drugs in the world – Ozempic (semaglutide) and Mounjaro (tirzepatide) – are now being scrutinised for a side effect that doctors rarely mention in the consultation room: […]